Phosphagenics Limited Information

Phosphagenics Limited is a biotechnology company that is based in Melbourne, Australia. Phosphagenics has developed a unique delivery technology based on tocopherol phosphate (Vitamin E phosphate). This platform technology, known as TPM® is able to deliver various molecules and pharmaceutical products into or through the skin, and to also improve delivery via other routes of administration. Phosphagenics is actively developing a number of products either on its own or via strategic partnerships with other companies, by designing formulations utilizing the TPM® technology. Phosphagenics is developing products across Pharmaceuticals (Transdermal, Topical, and Injectable), Animal Health, Nutritional Supplements, and Consumer Products (Skincare). Within Pharmaceuticals, the main area of R&D is Pain, with active development of an Oxymorphone Patch, Oxycodone Patch, Diclofenac Patch and Gel, and Lidocaine Patch and Gel, among others. Other key areas include Dermatology (Ketoconazole and Tretinoin) and Injectables (Antibiotics and Propofol). Phosphagenics shares are listed on the Australian Securities Exchange (ASX: POH). Phosphagenics ADR’s are also traded on the OTCQX in the USA.